Cambodia - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Cambodia Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 4.8% year on year. In 2019, the country was ranked number 121 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 139 Cases. Cambodia is overtaken by Sierra Leone, which was number 120 with 149 Cases and is followed by Cambodia at 135 Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 139.00 |
| 2018 | 133.00 |
| 2017 | 136.00 |
| 2016 | 101.00 |
| 2015 | 77.00 |
How does Cambodia rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 119 |
#119
Haiti
|
150 | 2019 | +59.6 % | +10.5 % | View data | |
| 121 |
#121
Cambodia
|
139 | 2019 | +4.5 % | +4.8 % | View data | |
| 124 |
#124
United States
|
131 | 2019 | -0.8 % | +3.9 % | View data | |